CORC  > 上海大学
Caspase polymorphisms and prognosis of hepatocellular carcinoma
Zhang Song[1]; Xiao Qianyi[2]; Shi Zhuqing[3]; Yu Guopeng[4]; Ma Xiao-Pin[5]; Chen Haitao[6]; Zhang Pengyin[7]; Shen Suqin[8]; Sai-Yin He-Xi Ge[9]; Chen Tao-Yang[10]
刊名PloS one
2017
卷号12页码:e0176802
ISSN号1932-6203
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/2224188
专题上海大学
作者单位1.Center for Genetic Translational Medicine and Prevention, School of Public Health, Fudan University, Shanghai, China.
2.State Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University, Shanghai, China.
3.Department of Urology, The 9th People's Hospital of Shanghai, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
4.Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu, China.
5.Central Laboratory, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, Henan, China.
6.College of Basic Medicine, Shanghai University of Medicine and Health Sciences, Shanghai, China.
7.Program for Personalized Cancer Care, NorthShore University HealthSystem, Pritzker School of Medicine, University of Chicago, Evanston, Illinois, United States of America.
推荐引用方式
GB/T 7714
Zhang Song[1],Xiao Qianyi[2],Shi Zhuqing[3],et al. Caspase polymorphisms and prognosis of hepatocellular carcinoma[J]. PloS one,2017,12:e0176802.
APA Zhang Song[1].,Xiao Qianyi[2].,Shi Zhuqing[3].,Yu Guopeng[4].,Ma Xiao-Pin[5].,...&Jiang De-Ke[20].(2017).Caspase polymorphisms and prognosis of hepatocellular carcinoma.PloS one,12,e0176802.
MLA Zhang Song[1],et al."Caspase polymorphisms and prognosis of hepatocellular carcinoma".PloS one 12(2017):e0176802.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace